Cancer Disease

Product	Indication	Specification	Regulatory status
Bortezomib	Lymphoma and Myeloma	In-house	none

In order to provide you with the best personalized and instant service, this website uses cookies to record and access your browsing information. By using this website, you agree to the technical support of cookies. Accept